CTFA/CHPA Urge Expanded Oral Health Care Indications
This article was originally published in The Rose Sheet
Executive Summary
FDA should broaden labeling guidance for the indications of OTC antigingivitis/antiplaque drug products to allow multiple descriptions of drug effects, the Joint Oral Care Task Group of the Consumer Healthcare Products Association and the Cosmetic, Toiletry and Fragrance Association recommends